浩欧博: 江苏浩欧博生物医药股份有限公司2025年第二次临时股东大会会议资料

Core Points - The company is holding its second extraordinary general meeting of shareholders in 2025 to ensure the rights of all shareholders and maintain order during the meeting [1] - The meeting will include a review and voting on various proposals, including the appointment of a new auditing firm and the election of independent directors [6][8] Meeting Procedures - Shareholders and their representatives must arrive 15 minutes before the meeting to register and present necessary identification documents [2] - The meeting will follow a specific agenda, including the announcement of attendance, reading of meeting guidelines, and voting on proposals [6] - Shareholders have the right to speak, inquire, and vote during the meeting, but must adhere to time limits and procedures [3][4] Voting and Proposals - The meeting will utilize both on-site and online voting methods, with specific time frames for each [5][6] - Proposal 1 involves changing the company's auditing firm from Lixin to Ernst & Young Huaming due to the former's long-term service [6][7] - Proposal 2 concerns the election of new independent directors following the resignation of two current directors, with candidates nominated by the board [8][9]